NCT00044473View on ClinicalTrials.gov

A Study of the Effectiness and Safety of Levofloxacin in Treating Children With a Rapid and Severe Onset of Infection and Inflammation of the Middle Ear That is Difficult to Treat

PHASE3CompletedINTERVENTIONAL
Enrollment

206

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

July 31, 2003

Conditions
Otitis Media
Interventions
DRUG

levofloxacin

All Listed Sponsors
lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00044473 - A Study of the Effectiness and Safety of Levofloxacin in Treating Children With a Rapid and Severe Onset of Infection and Inflammation of the Middle Ear That is Difficult to Treat | Biotech Hunter | Biotech Hunter